Specifically, they report that about 20% of ER+/HER2− breast cancers in the METABRIC [28] dataset harbor a shallow NF1 deletion (−1 copy number) correlating with poorer RFS and disease-specific survival [21]. This evidence concerns the gene ESR1 and breast cancer.